ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,664Medicare Part D Prescriptions Filled, Including Refills

Rank: 481 out of 2170

$462K Total Retail Price of All Prescriptions

Rank: 537 out of 2170

368 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,637 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 529 514 1 4
LISINOPRIL 393 342 2 3
PRAVASTATIN SODIUM 342 296 3 11
ATORVASTATIN CALCIUM 256 209 4 12
METOPROLOL SUCCINATE 234 229 5 13
LEVOTHYROXINE SODIUM 212 176 6 5
OMEPRAZOLE 208 172 7 2
SIMVASTATIN 180 180 8 1
TRAMADOL HCL 168 142 9 18
FUROSEMIDE 160 136 10 6
SYNTHROID 155 152 11 27
METFORMIN HCL ER 149 124 12 35
CITALOPRAM HBR 134 113 13 19
HYDROCHLOROTHIAZIDE 128 120 14 9
CRESTOR 128 125 14 24
GLIMEPIRIDE 123 111 16 31
LOSARTAN POTASSIUM 120 111 17 21
METFORMIN HCL 116 106 18 8
HYDROCODONE-ACETAMINOPHEN 114 102 S3 19 7
GABAPENTIN 108 74 20 14
METOPROLOL TARTRATE 105 101 21 10
SERTRALINE HCL 105 92 21 25
WARFARIN SODIUM 98 85 23 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 89 24 20
NEXIUM 93 79 25 22
TRAZODONE HCL 88 79 26 38
FLUTICASONE PROPIONATE 87 79 27 30
MIRTAZAPINE 83 68 28 46
FENOFIBRATE 72 70 29 57
ALLOPURINOL 72 60 29 29
TAMSULOSIN HCL 71 71 31 33
POTASSIUM CHLORIDE 70 49 32 16
AMLODIPINE BESYLATE-BENAZEPRIL 65 60 33 67
LIPITOR 63 54 34 83
CARVEDILOL 61 50 35 26
QUINAPRIL HCL 60 60 36 117
DOXAZOSIN MESYLATE 59 55 37 93
NIASPAN 58 58 38 103
ISOSORBIDE MONONITRATE ER 56 56 39 50
GLIPIZIDE XL 52 52 40 81
JANUVIA 52 52 40 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.